

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.58460629 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.33386097 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.32427316 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.28425049 |
| 5 | vocalization behavior (GO:0071625) | 5.19608188 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.18557258 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.04973862 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.03208105 |
| 9 | glutamate secretion (GO:0014047) | 5.01028028 |
| 10 | protein localization to synapse (GO:0035418) | 4.82819537 |
| 11 | neuron cell-cell adhesion (GO:0007158) | 4.82449517 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.80569007 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.62476791 |
| 14 | layer formation in cerebral cortex (GO:0021819) | 4.56180011 |
| 15 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.43690349 |
| 16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.35089094 |
| 17 | exploration behavior (GO:0035640) | 4.33443180 |
| 18 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.32140540 |
| 19 | regulation of synapse structural plasticity (GO:0051823) | 4.26091178 |
| 20 | regulation of synaptic vesicle transport (GO:1902803) | 4.25639543 |
| 21 | glutamate receptor signaling pathway (GO:0007215) | 4.18306163 |
| 22 | neurotransmitter secretion (GO:0007269) | 4.14829523 |
| 23 | positive regulation of synapse maturation (GO:0090129) | 4.12021334 |
| 24 | cellular potassium ion homeostasis (GO:0030007) | 4.08969626 |
| 25 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.08485324 |
| 26 | synaptic transmission, glutamatergic (GO:0035249) | 3.99905779 |
| 27 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.93350754 |
| 28 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.88811255 |
| 29 | neuronal action potential propagation (GO:0019227) | 3.88152139 |
| 30 | neuron recognition (GO:0008038) | 3.86501224 |
| 31 | neuron-neuron synaptic transmission (GO:0007270) | 3.85654749 |
| 32 | proline transport (GO:0015824) | 3.78497232 |
| 33 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.67797596 |
| 34 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.67776680 |
| 35 | gamma-aminobutyric acid transport (GO:0015812) | 3.66180118 |
| 36 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.66025967 |
| 37 | establishment of mitochondrion localization (GO:0051654) | 3.65485962 |
| 38 | postsynaptic membrane organization (GO:0001941) | 3.62401371 |
| 39 | dendritic spine morphogenesis (GO:0060997) | 3.60432902 |
| 40 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.59042496 |
| 41 | sodium ion export (GO:0071436) | 3.58472352 |
| 42 | long-term memory (GO:0007616) | 3.58273484 |
| 43 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.55438370 |
| 44 | dendrite morphogenesis (GO:0048813) | 3.54296827 |
| 45 | synaptic vesicle endocytosis (GO:0048488) | 3.53956073 |
| 46 | neuronal ion channel clustering (GO:0045161) | 3.52790497 |
| 47 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.48867189 |
| 48 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.48083295 |
| 49 | axonal fasciculation (GO:0007413) | 3.47552551 |
| 50 | neurotransmitter transport (GO:0006836) | 3.46540552 |
| 51 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.46379276 |
| 52 | cerebellar granule cell differentiation (GO:0021707) | 3.45242903 |
| 53 | cellular sodium ion homeostasis (GO:0006883) | 3.39506335 |
| 54 | transmission of nerve impulse (GO:0019226) | 3.38783396 |
| 55 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.37012627 |
| 56 | response to auditory stimulus (GO:0010996) | 3.36634455 |
| 57 | regulation of postsynaptic membrane potential (GO:0060078) | 3.36214962 |
| 58 | cell migration in hindbrain (GO:0021535) | 3.34878404 |
| 59 | positive regulation of membrane potential (GO:0045838) | 3.32472148 |
| 60 | cell communication by electrical coupling (GO:0010644) | 3.32354002 |
| 61 | innervation (GO:0060384) | 3.31738004 |
| 62 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.31086706 |
| 63 | long-term synaptic potentiation (GO:0060291) | 3.30685039 |
| 64 | auditory behavior (GO:0031223) | 3.29915975 |
| 65 | activation of protein kinase A activity (GO:0034199) | 3.29793787 |
| 66 | regulation of neurotransmitter secretion (GO:0046928) | 3.29179237 |
| 67 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.29033097 |
| 68 | synapse assembly (GO:0007416) | 3.27745805 |
| 69 | regulation of vesicle fusion (GO:0031338) | 3.27399965 |
| 70 | regulation of synaptic plasticity (GO:0048167) | 3.24830278 |
| 71 | mechanosensory behavior (GO:0007638) | 3.24664802 |
| 72 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.24596555 |
| 73 | response to pheromone (GO:0019236) | 3.24370969 |
| 74 | presynaptic membrane assembly (GO:0097105) | 3.23099717 |
| 75 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.18229941 |
| 76 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.17719242 |
| 77 | regulation of synapse maturation (GO:0090128) | 3.17386560 |
| 78 | regulation of neurotransmitter levels (GO:0001505) | 3.17222235 |
| 79 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.17009310 |
| 80 | L-amino acid import (GO:0043092) | 3.16723855 |
| 81 | potassium ion homeostasis (GO:0055075) | 3.11746654 |
| 82 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.11553554 |
| 83 | prepulse inhibition (GO:0060134) | 3.11522791 |
| 84 | positive regulation of dendritic spine development (GO:0060999) | 3.08749130 |
| 85 | regulation of neurotransmitter transport (GO:0051588) | 3.08611853 |
| 86 | presynaptic membrane organization (GO:0097090) | 3.08355374 |
| 87 | neuromuscular process controlling balance (GO:0050885) | 3.07321187 |
| 88 | membrane depolarization during action potential (GO:0086010) | 3.07176912 |
| 89 | behavioral defense response (GO:0002209) | 3.04999598 |
| 90 | behavioral fear response (GO:0001662) | 3.04999598 |
| 91 | dendritic spine organization (GO:0097061) | 3.04914536 |
| 92 | amino acid import (GO:0043090) | 3.04720100 |
| 93 | response to histamine (GO:0034776) | 3.03056978 |
| 94 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.02783478 |
| 95 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.00792644 |
| 96 | nucleobase catabolic process (GO:0046113) | 3.00147291 |
| 97 | positive regulation of synapse assembly (GO:0051965) | 2.98602624 |
| 98 | membrane depolarization (GO:0051899) | 2.97434224 |
| 99 | axon ensheathment in central nervous system (GO:0032291) | 2.97370877 |
| 100 | central nervous system myelination (GO:0022010) | 2.97370877 |
| 101 | vesicle transport along microtubule (GO:0047496) | 2.97195358 |
| 102 | organelle transport along microtubule (GO:0072384) | 2.96298108 |
| 103 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.95945205 |
| 104 | learning (GO:0007612) | 2.95294413 |
| 105 | negative regulation of microtubule polymerization (GO:0031115) | 2.94062773 |
| 106 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.92415784 |
| 107 | acidic amino acid transport (GO:0015800) | 2.91946918 |
| 108 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.91630573 |
| 109 | detection of calcium ion (GO:0005513) | 2.90792992 |
| 110 | fear response (GO:0042596) | 2.90563460 |
| 111 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.89829713 |
| 112 | regulation of dendritic spine development (GO:0060998) | 2.89207216 |
| 113 | potassium ion import (GO:0010107) | 2.87425998 |
| 114 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.87217723 |
| 115 | membrane hyperpolarization (GO:0060081) | 2.87108915 |
| 116 | synapse organization (GO:0050808) | 2.86912076 |
| 117 | synaptic transmission (GO:0007268) | 2.85747581 |
| 118 | establishment of synaptic vesicle localization (GO:0097480) | 2.84490420 |
| 119 | synaptic vesicle transport (GO:0048489) | 2.84490420 |
| 120 | neurotransmitter uptake (GO:0001504) | 2.82805304 |
| 121 | startle response (GO:0001964) | 2.81789334 |
| 122 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.81035586 |
| 123 | mitochondrion transport along microtubule (GO:0047497) | 2.81035586 |
| 124 | cochlea development (GO:0090102) | 2.80525896 |
| 125 | C4-dicarboxylate transport (GO:0015740) | 2.79957910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.66672534 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.82465173 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.12232898 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.01618041 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.00145472 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.75854185 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.63602015 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.63602015 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.60925980 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55652043 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.54687844 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.53078268 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.50717387 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.47714201 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.45664103 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.35919425 |
| 17 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.31905311 |
| 18 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.27230851 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.27126162 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.22656509 |
| 21 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.21728683 |
| 22 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.20574894 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.16630744 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.16419109 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.13699825 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.02310129 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.94955461 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.87971592 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.83718907 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.80696401 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.78400703 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.75187548 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66291774 |
| 34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.62505403 |
| 35 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.59449008 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.58104723 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.57354780 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.46679967 |
| 39 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.43910077 |
| 40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42752484 |
| 41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.38024891 |
| 42 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37799272 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.36677303 |
| 44 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.36380703 |
| 45 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35914089 |
| 46 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32681001 |
| 47 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32499818 |
| 48 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.31421905 |
| 49 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.31333607 |
| 50 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.29809041 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28918307 |
| 52 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28466403 |
| 53 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25958762 |
| 54 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25178314 |
| 55 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.23941987 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23489113 |
| 57 | STAT3_23295773_ChIP-Seq_U87_Human | 1.21760074 |
| 58 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.20808719 |
| 59 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.18483066 |
| 60 | AR_19668381_ChIP-Seq_PC3_Human | 1.18107979 |
| 61 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.15725871 |
| 62 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.14585042 |
| 63 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13975344 |
| 64 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.13399945 |
| 65 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12863424 |
| 66 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11228518 |
| 67 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11067863 |
| 68 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08260140 |
| 69 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.07845437 |
| 70 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07170878 |
| 71 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07009637 |
| 72 | TCF4_23295773_ChIP-Seq_U87_Human | 1.06667766 |
| 73 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.05651961 |
| 74 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05227815 |
| 75 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04133864 |
| 76 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.02705734 |
| 77 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02589028 |
| 78 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02404308 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01204810 |
| 80 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.00169723 |
| 81 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99444731 |
| 82 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99354251 |
| 83 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98962687 |
| 84 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.98784257 |
| 85 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.98019874 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97873596 |
| 87 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97037562 |
| 88 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96806528 |
| 89 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96806528 |
| 90 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96524095 |
| 91 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96013238 |
| 92 | FUS_26573619_Chip-Seq_HEK293_Human | 0.95628537 |
| 93 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95018873 |
| 94 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94274080 |
| 95 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.93415221 |
| 96 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.93038218 |
| 97 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92567098 |
| 98 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.92393719 |
| 99 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.92034688 |
| 100 | JUN_21703547_ChIP-Seq_K562_Human | 0.91544235 |
| 101 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.90821849 |
| 102 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90086346 |
| 103 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.89097445 |
| 104 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89093899 |
| 105 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.88795862 |
| 106 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.87950068 |
| 107 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87936891 |
| 108 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87816158 |
| 109 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.87434170 |
| 110 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.87405719 |
| 111 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.87126052 |
| 112 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.86020544 |
| 113 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.85209451 |
| 114 | VDR_22108803_ChIP-Seq_LS180_Human | 0.84862992 |
| 115 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.83995975 |
| 116 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83827993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.91316196 |
| 2 | MP0003880_abnormal_central_pattern | 4.62581174 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.99912000 |
| 4 | MP0004270_analgesia | 3.77001270 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.28655821 |
| 6 | MP0009745_abnormal_behavioral_response | 3.20371839 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.05384796 |
| 8 | MP0005423_abnormal_somatic_nervous | 3.04902473 |
| 9 | MP0009046_muscle_twitch | 2.96965246 |
| 10 | MP0002064_seizures | 2.95089888 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.80774532 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.74957236 |
| 13 | MP0002735_abnormal_chemical_nociception | 2.55513115 |
| 14 | MP0001486_abnormal_startle_reflex | 2.47648603 |
| 15 | MP0002272_abnormal_nervous_system | 2.43636009 |
| 16 | MP0002736_abnormal_nociception_after | 2.41367000 |
| 17 | MP0001440_abnormal_grooming_behavior | 2.30393802 |
| 18 | MP0002733_abnormal_thermal_nociception | 2.26183727 |
| 19 | MP0003329_amyloid_beta_deposits | 2.19293160 |
| 20 | MP0000778_abnormal_nervous_system | 2.16376923 |
| 21 | MP0002822_catalepsy | 2.13998897 |
| 22 | MP0006276_abnormal_autonomic_nervous | 2.10411360 |
| 23 | MP0001970_abnormal_pain_threshold | 2.08797030 |
| 24 | MP0004858_abnormal_nervous_system | 2.07595075 |
| 25 | MP0001501_abnormal_sleep_pattern | 2.07549991 |
| 26 | MP0002184_abnormal_innervation | 2.07274220 |
| 27 | MP0002067_abnormal_sensory_capabilities | 2.06572624 |
| 28 | MP0001984_abnormal_olfaction | 1.98757254 |
| 29 | MP0004924_abnormal_behavior | 1.86541239 |
| 30 | MP0005386_behavior/neurological_phenoty | 1.86541239 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.85721285 |
| 32 | MP0002557_abnormal_social/conspecific_i | 1.82681679 |
| 33 | MP0008569_lethality_at_weaning | 1.80744871 |
| 34 | MP0004811_abnormal_neuron_physiology | 1.72632820 |
| 35 | MP0002909_abnormal_adrenal_gland | 1.66447913 |
| 36 | MP0000955_abnormal_spinal_cord | 1.63532532 |
| 37 | MP0004885_abnormal_endolymph | 1.54625038 |
| 38 | MP0000566_synostosis | 1.54515499 |
| 39 | MP0001529_abnormal_vocalization | 1.53732582 |
| 40 | MP0005646_abnormal_pituitary_gland | 1.53476854 |
| 41 | MP0002882_abnormal_neuron_morphology | 1.50531942 |
| 42 | MP0001502_abnormal_circadian_rhythm | 1.50249199 |
| 43 | MP0003879_abnormal_hair_cell | 1.44825620 |
| 44 | MP0002066_abnormal_motor_capabilities/c | 1.41773674 |
| 45 | MP0001905_abnormal_dopamine_level | 1.35473409 |
| 46 | MP0005645_abnormal_hypothalamus_physiol | 1.34790619 |
| 47 | MP0004142_abnormal_muscle_tone | 1.32543885 |
| 48 | MP0005551_abnormal_eye_electrophysiolog | 1.27178980 |
| 49 | MP0003633_abnormal_nervous_system | 1.23713140 |
| 50 | MP0002152_abnormal_brain_morphology | 1.16999329 |
| 51 | MP0003787_abnormal_imprinting | 1.13247687 |
| 52 | MP0001188_hyperpigmentation | 1.11230770 |
| 53 | MP0003122_maternal_imprinting | 1.10359648 |
| 54 | MP0003631_nervous_system_phenotype | 1.09205136 |
| 55 | MP0004145_abnormal_muscle_electrophysio | 1.06138565 |
| 56 | MP0004742_abnormal_vestibular_system | 1.06090886 |
| 57 | MP0010386_abnormal_urinary_bladder | 1.06058579 |
| 58 | MP0002229_neurodegeneration | 1.04722650 |
| 59 | MP0000604_amyloidosis | 1.03508881 |
| 60 | MP0000751_myopathy | 1.03238767 |
| 61 | MP0002638_abnormal_pupillary_reflex | 0.97467741 |
| 62 | MP0002837_dystrophic_cardiac_calcinosis | 0.97409089 |
| 63 | MP0003634_abnormal_glial_cell | 0.96069480 |
| 64 | MP0008875_abnormal_xenobiotic_pharmacok | 0.95327515 |
| 65 | MP0008872_abnormal_physiological_respon | 0.95257890 |
| 66 | MP0005248_abnormal_Harderian_gland | 0.93400018 |
| 67 | MP0003121_genomic_imprinting | 0.91752312 |
| 68 | MP0002069_abnormal_eating/drinking_beha | 0.91584026 |
| 69 | MP0001346_abnormal_lacrimal_gland | 0.91414504 |
| 70 | MP0002752_abnormal_somatic_nervous | 0.90765104 |
| 71 | MP0005499_abnormal_olfactory_system | 0.90446958 |
| 72 | MP0005394_taste/olfaction_phenotype | 0.90446958 |
| 73 | MP0002090_abnormal_vision | 0.90283253 |
| 74 | MP0000631_abnormal_neuroendocrine_gland | 0.89945869 |
| 75 | MP0002653_abnormal_ependyma_morphology | 0.87310097 |
| 76 | MP0001963_abnormal_hearing_physiology | 0.87022258 |
| 77 | MP0004085_abnormal_heartbeat | 0.86105849 |
| 78 | MP0003137_abnormal_impulse_conducting | 0.86035870 |
| 79 | MP0004233_abnormal_muscle_weight | 0.85771493 |
| 80 | MP0000569_abnormal_digit_pigmentation | 0.85133324 |
| 81 | MP0003632_abnormal_nervous_system | 0.84529719 |
| 82 | MP0006072_abnormal_retinal_apoptosis | 0.83100396 |
| 83 | MP0005535_abnormal_body_temperature | 0.82226147 |
| 84 | MP0003123_paternal_imprinting | 0.81885041 |
| 85 | MP0004215_abnormal_myocardial_fiber | 0.81566248 |
| 86 | MP0004133_heterotaxia | 0.80477241 |
| 87 | MP0003690_abnormal_glial_cell | 0.78421584 |
| 88 | MP0000013_abnormal_adipose_tissue | 0.76731050 |
| 89 | MP0003938_abnormal_ear_development | 0.75128476 |
| 90 | MP0008789_abnormal_olfactory_epithelium | 0.74704561 |
| 91 | MP0008874_decreased_physiological_sensi | 0.73123756 |
| 92 | MP0001177_atelectasis | 0.71081210 |
| 93 | MP0002234_abnormal_pharynx_morphology | 0.67567171 |
| 94 | MP0002876_abnormal_thyroid_physiology | 0.67046846 |
| 95 | MP0001664_abnormal_digestion | 0.66787576 |
| 96 | MP0001299_abnormal_eye_distance/ | 0.66661912 |
| 97 | MP0001485_abnormal_pinna_reflex | 0.65646950 |
| 98 | MP0003861_abnormal_nervous_system | 0.65217058 |
| 99 | MP0004147_increased_porphyrin_level | 0.64940319 |
| 100 | MP0000639_abnormal_adrenal_gland | 0.63666853 |
| 101 | MP0004484_altered_response_of | 0.63205986 |
| 102 | MP0005623_abnormal_meninges_morphology | 0.62883297 |
| 103 | MP0005187_abnormal_penis_morphology | 0.62769189 |
| 104 | MP0000579_abnormal_nail_morphology | 0.61187410 |
| 105 | MP0008961_abnormal_basal_metabolism | 0.60504758 |
| 106 | MP0005253_abnormal_eye_physiology | 0.60192807 |
| 107 | MP0000920_abnormal_myelination | 0.59915510 |
| 108 | MP0005409_darkened_coat_color | 0.59904150 |
| 109 | MP0000026_abnormal_inner_ear | 0.58035184 |
| 110 | MP0004043_abnormal_pH_regulation | 0.55900332 |
| 111 | MP0003075_altered_response_to | 0.55307870 |
| 112 | MP0001943_abnormal_respiration | 0.54142852 |
| 113 | MP0010769_abnormal_survival | 0.52315970 |
| 114 | MP0002082_postnatal_lethality | 0.51602311 |
| 115 | MP0010770_preweaning_lethality | 0.51602311 |
| 116 | MP0003956_abnormal_body_size | 0.49300789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.57999881 |
| 2 | Myokymia (HP:0002411) | 6.17560152 |
| 3 | Focal seizures (HP:0007359) | 5.17032828 |
| 4 | Visual hallucinations (HP:0002367) | 5.04277558 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.93707358 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 4.41433182 |
| 7 | Atonic seizures (HP:0010819) | 4.19200146 |
| 8 | Febrile seizures (HP:0002373) | 4.09480067 |
| 9 | Absence seizures (HP:0002121) | 4.01166586 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 3.95654627 |
| 11 | Action tremor (HP:0002345) | 3.76768539 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.68672012 |
| 13 | Dialeptic seizures (HP:0011146) | 3.60902208 |
| 14 | Broad-based gait (HP:0002136) | 3.58301152 |
| 15 | Mutism (HP:0002300) | 3.51383465 |
| 16 | Neurofibrillary tangles (HP:0002185) | 3.36171807 |
| 17 | Hyperventilation (HP:0002883) | 3.28996125 |
| 18 | Cerebral inclusion bodies (HP:0100314) | 3.24963721 |
| 19 | Ankle clonus (HP:0011448) | 3.23675411 |
| 20 | Abnormality of binocular vision (HP:0011514) | 3.17255570 |
| 21 | Diplopia (HP:0000651) | 3.17255570 |
| 22 | Poor eye contact (HP:0000817) | 3.13684128 |
| 23 | Truncal ataxia (HP:0002078) | 3.11158742 |
| 24 | Limb dystonia (HP:0002451) | 3.10843064 |
| 25 | Abnormal eating behavior (HP:0100738) | 3.10773091 |
| 26 | Dysdiadochokinesis (HP:0002075) | 3.06843059 |
| 27 | Gaze-evoked nystagmus (HP:0000640) | 3.02074896 |
| 28 | Depression (HP:0000716) | 3.01834671 |
| 29 | Polyphagia (HP:0002591) | 3.01454774 |
| 30 | Excessive salivation (HP:0003781) | 2.99668391 |
| 31 | Drooling (HP:0002307) | 2.99668391 |
| 32 | Hemiparesis (HP:0001269) | 2.99274068 |
| 33 | Papilledema (HP:0001085) | 2.93159216 |
| 34 | Genetic anticipation (HP:0003743) | 2.84547501 |
| 35 | Anxiety (HP:0000739) | 2.84243840 |
| 36 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.81539621 |
| 37 | Amblyopia (HP:0000646) | 2.81375930 |
| 38 | Abnormal social behavior (HP:0012433) | 2.80107295 |
| 39 | Impaired social interactions (HP:0000735) | 2.80107295 |
| 40 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.79268271 |
| 41 | Dysmetria (HP:0001310) | 2.78974530 |
| 42 | Insidious onset (HP:0003587) | 2.77911437 |
| 43 | Termporal pattern (HP:0011008) | 2.77911437 |
| 44 | Abnormality of the corticospinal tract (HP:0002492) | 2.72948155 |
| 45 | Epileptiform EEG discharges (HP:0011182) | 2.69642775 |
| 46 | Megalencephaly (HP:0001355) | 2.68816929 |
| 47 | Amyotrophic lateral sclerosis (HP:0007354) | 2.68096797 |
| 48 | EEG with generalized epileptiform discharges (HP:0011198) | 2.63733803 |
| 49 | Scanning speech (HP:0002168) | 2.62042207 |
| 50 | Urinary urgency (HP:0000012) | 2.61900058 |
| 51 | Pheochromocytoma (HP:0002666) | 2.55330388 |
| 52 | Abnormality of the lower motor neuron (HP:0002366) | 2.55294692 |
| 53 | Torticollis (HP:0000473) | 2.54409059 |
| 54 | Gait imbalance (HP:0002141) | 2.52230296 |
| 55 | Spastic gait (HP:0002064) | 2.50288960 |
| 56 | Progressive inability to walk (HP:0002505) | 2.50034793 |
| 57 | Postural instability (HP:0002172) | 2.48526360 |
| 58 | Impaired smooth pursuit (HP:0007772) | 2.42453219 |
| 59 | Hypsarrhythmia (HP:0002521) | 2.41161807 |
| 60 | Bradykinesia (HP:0002067) | 2.36741801 |
| 61 | Agitation (HP:0000713) | 2.33078888 |
| 62 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.32970457 |
| 63 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.32970457 |
| 64 | Focal dystonia (HP:0004373) | 2.30161247 |
| 65 | Hemiplegia (HP:0002301) | 2.29111838 |
| 66 | Abnormality of the labia minora (HP:0012880) | 2.27829081 |
| 67 | Split foot (HP:0001839) | 2.26415584 |
| 68 | Stereotypic behavior (HP:0000733) | 2.25798749 |
| 69 | Intention tremor (HP:0002080) | 2.25241648 |
| 70 | Fetal akinesia sequence (HP:0001989) | 2.22821615 |
| 71 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.20888714 |
| 72 | Inability to walk (HP:0002540) | 2.19687125 |
| 73 | Lower limb muscle weakness (HP:0007340) | 2.17182193 |
| 74 | Neuroendocrine neoplasm (HP:0100634) | 2.17036354 |
| 75 | Absent speech (HP:0001344) | 2.13594016 |
| 76 | Akinesia (HP:0002304) | 2.12336175 |
| 77 | Craniofacial dystonia (HP:0012179) | 2.11750108 |
| 78 | Spastic tetraplegia (HP:0002510) | 2.09041713 |
| 79 | Obstructive sleep apnea (HP:0002870) | 2.05020884 |
| 80 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.03877732 |
| 81 | Status epilepticus (HP:0002133) | 2.02972933 |
| 82 | Dysmetric saccades (HP:0000641) | 2.02693817 |
| 83 | Poor suck (HP:0002033) | 2.02620698 |
| 84 | Specific learning disability (HP:0001328) | 2.01765822 |
| 85 | Tetraplegia (HP:0002445) | 1.99461800 |
| 86 | Abnormality of salivation (HP:0100755) | 1.97369126 |
| 87 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.97276747 |
| 88 | Hypoplasia of the brainstem (HP:0002365) | 1.97276747 |
| 89 | Generalized myoclonic seizures (HP:0002123) | 1.96477419 |
| 90 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.95973037 |
| 91 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.95973037 |
| 92 | Abnormal ciliary motility (HP:0012262) | 1.92934428 |
| 93 | Sleep apnea (HP:0010535) | 1.92625885 |
| 94 | Failure to thrive in infancy (HP:0001531) | 1.92015316 |
| 95 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.91883818 |
| 96 | Hypoventilation (HP:0002791) | 1.91305955 |
| 97 | Gait ataxia (HP:0002066) | 1.91114842 |
| 98 | Neuronal loss in central nervous system (HP:0002529) | 1.89463659 |
| 99 | Impaired vibratory sensation (HP:0002495) | 1.88530587 |
| 100 | Inappropriate behavior (HP:0000719) | 1.88091344 |
| 101 | Cerebral hypomyelination (HP:0006808) | 1.87901401 |
| 102 | Delusions (HP:0000746) | 1.86754727 |
| 103 | Apathy (HP:0000741) | 1.85228954 |
| 104 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.84745767 |
| 105 | Lissencephaly (HP:0001339) | 1.84423374 |
| 106 | Genital tract atresia (HP:0001827) | 1.83329051 |
| 107 | Medial flaring of the eyebrow (HP:0010747) | 1.83258147 |
| 108 | Insomnia (HP:0100785) | 1.83243368 |
| 109 | Ventricular fibrillation (HP:0001663) | 1.82769309 |
| 110 | Pancreatic fibrosis (HP:0100732) | 1.82639976 |
| 111 | Psychosis (HP:0000709) | 1.80905533 |
| 112 | Nephrogenic diabetes insipidus (HP:0009806) | 1.80101135 |
| 113 | Incomplete penetrance (HP:0003829) | 1.78994085 |
| 114 | Rigidity (HP:0002063) | 1.78583275 |
| 115 | Congenital primary aphakia (HP:0007707) | 1.78556192 |
| 116 | True hermaphroditism (HP:0010459) | 1.77469830 |
| 117 | Clonus (HP:0002169) | 1.77304969 |
| 118 | Retinal dysplasia (HP:0007973) | 1.73812513 |
| 119 | Dyskinesia (HP:0100660) | 1.73464612 |
| 120 | Hypoplasia of the corpus callosum (HP:0002079) | 1.70258771 |
| 121 | Vaginal atresia (HP:0000148) | 1.69568244 |
| 122 | Muscular hypotonia of the trunk (HP:0008936) | 1.67737434 |
| 123 | Diminished movement (HP:0002374) | 1.66817447 |
| 124 | Hepatoblastoma (HP:0002884) | 1.65954490 |
| 125 | Rhinitis (HP:0012384) | 1.65403349 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.78299147 |
| 2 | MAP3K9 | 3.89057084 |
| 3 | NTRK3 | 3.76472891 |
| 4 | EPHA4 | 3.43385194 |
| 5 | MAP3K4 | 3.13023963 |
| 6 | MINK1 | 2.85769417 |
| 7 | MAP2K7 | 2.55995616 |
| 8 | CASK | 2.48162099 |
| 9 | NTRK2 | 2.47982475 |
| 10 | DAPK2 | 2.23805507 |
| 11 | PAK6 | 2.10882257 |
| 12 | PHKG2 | 2.09555508 |
| 13 | PHKG1 | 2.09555508 |
| 14 | KSR2 | 1.84395341 |
| 15 | MAP3K12 | 1.83460305 |
| 16 | MAP2K4 | 1.82329216 |
| 17 | MAPK13 | 1.76942187 |
| 18 | KSR1 | 1.69384274 |
| 19 | NTRK1 | 1.62051700 |
| 20 | CDK5 | 1.51709915 |
| 21 | PLK2 | 1.51398061 |
| 22 | CAMKK1 | 1.50037089 |
| 23 | PRKD3 | 1.36966041 |
| 24 | TNIK | 1.32338705 |
| 25 | SIK2 | 1.32325906 |
| 26 | GRK5 | 1.31791721 |
| 27 | DAPK1 | 1.27693615 |
| 28 | LATS2 | 1.26959654 |
| 29 | PNCK | 1.26171927 |
| 30 | PRKCG | 1.20829905 |
| 31 | LMTK2 | 1.20479905 |
| 32 | CAMKK2 | 1.19395158 |
| 33 | CDK19 | 1.16975033 |
| 34 | RIPK4 | 1.16397831 |
| 35 | PRPF4B | 1.15781995 |
| 36 | CSNK1A1L | 1.12200015 |
| 37 | ARAF | 1.11861631 |
| 38 | EPHA3 | 1.01816215 |
| 39 | CSNK1G2 | 1.01323921 |
| 40 | CAMK2A | 1.00582885 |
| 41 | DYRK2 | 0.96982945 |
| 42 | DYRK1A | 0.96110328 |
| 43 | STK38 | 0.95689634 |
| 44 | UHMK1 | 0.93439956 |
| 45 | CDK18 | 0.93077972 |
| 46 | CSNK1G1 | 0.93064909 |
| 47 | TYRO3 | 0.91660144 |
| 48 | CDK14 | 0.91427864 |
| 49 | MAP3K13 | 0.90537890 |
| 50 | SGK494 | 0.89481006 |
| 51 | SGK223 | 0.89481006 |
| 52 | CDK15 | 0.89279130 |
| 53 | MAP3K2 | 0.87234113 |
| 54 | FES | 0.86468721 |
| 55 | PAK3 | 0.86198273 |
| 56 | RET | 0.85372333 |
| 57 | MARK2 | 0.82755743 |
| 58 | CDK11A | 0.76571818 |
| 59 | CAMK2B | 0.76518496 |
| 60 | SIK3 | 0.74606430 |
| 61 | STK11 | 0.74057882 |
| 62 | STK39 | 0.72605393 |
| 63 | CAMK1 | 0.72022117 |
| 64 | TAOK1 | 0.69978809 |
| 65 | TESK1 | 0.68632776 |
| 66 | ERBB3 | 0.68181901 |
| 67 | OXSR1 | 0.66795467 |
| 68 | TRIM28 | 0.66315477 |
| 69 | SGK2 | 0.66100125 |
| 70 | NEK6 | 0.66015518 |
| 71 | PINK1 | 0.65047105 |
| 72 | PTK2B | 0.64741382 |
| 73 | PRKCE | 0.64675128 |
| 74 | PRKCZ | 0.62436844 |
| 75 | MAP4K2 | 0.61518523 |
| 76 | CCNB1 | 0.61218637 |
| 77 | MAP3K6 | 0.60504269 |
| 78 | PRKCH | 0.59379445 |
| 79 | NME1 | 0.59116798 |
| 80 | SGK1 | 0.58432704 |
| 81 | FRK | 0.55948336 |
| 82 | PKN1 | 0.55195548 |
| 83 | MAPK12 | 0.55186384 |
| 84 | CAMK1G | 0.54142271 |
| 85 | RAF1 | 0.54051716 |
| 86 | AKT3 | 0.53057825 |
| 87 | MAPK15 | 0.52579804 |
| 88 | FGFR2 | 0.52055598 |
| 89 | WNK3 | 0.51809691 |
| 90 | ERBB2 | 0.51283075 |
| 91 | FER | 0.50395044 |
| 92 | WNK4 | 0.49973903 |
| 93 | CSNK1G3 | 0.49313542 |
| 94 | CAMK2D | 0.49031408 |
| 95 | FGR | 0.48365355 |
| 96 | BCR | 0.47375902 |
| 97 | BMPR2 | 0.47216736 |
| 98 | SGK3 | 0.45885279 |
| 99 | FYN | 0.44569958 |
| 100 | PRKACA | 0.43707174 |
| 101 | RPS6KA3 | 0.42998854 |
| 102 | CSNK1D | 0.42912790 |
| 103 | CAMK2G | 0.42850764 |
| 104 | NEK1 | 0.41242146 |
| 105 | BRSK1 | 0.40067838 |
| 106 | CSNK1A1 | 0.39974424 |
| 107 | PRKG1 | 0.39343654 |
| 108 | PDPK1 | 0.38945970 |
| 109 | MAP2K1 | 0.38727687 |
| 110 | SCYL2 | 0.38439262 |
| 111 | RPS6KA2 | 0.37938200 |
| 112 | PDK1 | 0.37580015 |
| 113 | RIPK1 | 0.37185256 |
| 114 | CSNK1E | 0.36824423 |
| 115 | RPS6KB1 | 0.36689863 |
| 116 | LIMK1 | 0.36396981 |
| 117 | ROCK2 | 0.35277015 |
| 118 | PRKCA | 0.35068095 |
| 119 | PRKAA1 | 0.34909949 |
| 120 | MAPK10 | 0.33652331 |
| 121 | CAMK4 | 0.33436863 |
| 122 | ADRBK1 | 0.32733729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.80171764 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.39171708 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.77899071 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.75706410 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.68067550 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.64087629 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.56795679 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.52218324 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.44659328 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.27940387 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.21514819 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.21465514 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.10006755 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.99439411 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.90082186 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.88910570 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.75986567 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.74259816 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.73444166 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.70627437 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.70365122 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.64518711 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.62807322 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.60180442 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.59520734 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.54197617 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.48262553 |
| 28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.42348403 |
| 29 | Gap junction_Homo sapiens_hsa04540 | 1.40948040 |
| 30 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.37636943 |
| 31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.35667326 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.28098651 |
| 33 | Axon guidance_Homo sapiens_hsa04360 | 1.27143516 |
| 34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.25782533 |
| 35 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.18291029 |
| 36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.17283710 |
| 37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.15504885 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09011777 |
| 39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.08786881 |
| 40 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.07325802 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.05266936 |
| 42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.03191695 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02425723 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 1.00343782 |
| 45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00105915 |
| 46 | Melanogenesis_Homo sapiens_hsa04916 | 0.96495316 |
| 47 | Glioma_Homo sapiens_hsa05214 | 0.94779223 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94659219 |
| 49 | Phototransduction_Homo sapiens_hsa04744 | 0.93583607 |
| 50 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.89748379 |
| 51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.86416394 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.86011130 |
| 53 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85682048 |
| 54 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.84922518 |
| 55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84883724 |
| 56 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.83785540 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80100538 |
| 58 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77909319 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76793658 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75659570 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74348899 |
| 62 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.74275873 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70134428 |
| 64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69032234 |
| 65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68424241 |
| 66 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66883227 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66429948 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66283617 |
| 69 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64025429 |
| 70 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.63813570 |
| 71 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63130797 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61043837 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60422715 |
| 74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.59096148 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57710830 |
| 76 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57261267 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.57118899 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56576300 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56143220 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 0.55859073 |
| 81 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.55828775 |
| 82 | Alcoholism_Homo sapiens_hsa05034 | 0.54644472 |
| 83 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.54344422 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53146497 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53048800 |
| 86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53033458 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52216685 |
| 88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52052425 |
| 89 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.51122650 |
| 90 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49603947 |
| 91 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.48735891 |
| 92 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47962316 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46882722 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46826395 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45672399 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45524002 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44554381 |
| 98 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.44367937 |
| 99 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44035537 |
| 100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43880266 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43864623 |
| 102 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42613259 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42086430 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41661693 |
| 105 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.40608377 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40351729 |
| 107 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39206614 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.39180989 |
| 109 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37465863 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.35978931 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35872914 |
| 112 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35662919 |
| 113 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.35349371 |
| 114 | Colorectal cancer_Homo sapiens_hsa05210 | 0.35260063 |
| 115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35198581 |
| 116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34782495 |
| 117 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.34722166 |
| 118 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.34078984 |
| 119 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33197964 |
| 120 | Parkinsons disease_Homo sapiens_hsa05012 | 0.33168690 |
| 121 | Tight junction_Homo sapiens_hsa04530 | 0.32683473 |
| 122 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.32536708 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32519429 |
| 124 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.32418220 |
| 125 | ABC transporters_Homo sapiens_hsa02010 | 0.31846413 |
| 126 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.30943096 |
| 127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30392897 |
| 128 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.28074302 |
| 129 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27928461 |

